becton dickinson & co. - BDX

BDX

Close Chg Chg %
226.01 0.38 0.17%

Closed Market

226.39

+0.38 (0.17%)

Volume: 1.63M

Last Updated:

Apr 2, 2025, 3:59 PM EDT

Company Overview: becton dickinson & co. - BDX

BDX Key Data

Open

$225.57

Day Range

223.54 - 226.80

52 Week Range

218.75 - 251.93

Market Cap

$64.90B

Shares Outstanding

287.14M

Public Float

286.60M

Beta

0.36

Rev. Per Employee

N/A

P/E Ratio

37.55

EPS

$6.04

Yield

176.08%

Dividend

$1.04

EX-DIVIDEND DATE

Mar 10, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

1.96M

 

BDX Performance

1 Week
 
-0.47%
 
1 Month
 
0.39%
 
3 Months
 
-0.89%
 
1 Year
 
-8.02%
 
5 Years
 
2.18%
 

BDX Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 19
Full Ratings ➔

About becton dickinson & co. - BDX

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

BDX At a Glance

Becton, Dickinson & Co.
1 Becton Drive
Franklin Lakes, New Jersey 07417-1880
Phone 1-201-847-6800 Revenue 20.18B
Industry Medical Specialties Net Income 1.71B
Sector Health Technology 2024 Sales Growth 4.161%
Fiscal Year-end 09 / 2025 Employees 74,000
View SEC Filings

BDX Valuation

P/E Current 37.794
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 41.151
Price to Sales Ratio 3.477
Price to Book Ratio 2.692
Price to Cash Flow Ratio 18.474
Enterprise Value to EBITDA 16.972
Enterprise Value to Sales 4.40
Total Debt to Enterprise Value 0.236

BDX Efficiency

Revenue/Employee 272,675.676
Income Per Employee 23,040.541
Receivables Turnover 6.653
Total Asset Turnover 0.367

BDX Liquidity

Current Ratio 1.169
Quick Ratio 0.74
Cash Ratio 0.257

BDX Profitability

Gross Margin 45.223
Operating Margin 15.299
Pretax Margin 9.937
Net Margin 8.45
Return on Assets 3.098
Return on Equity 6.597
Return on Total Capital 3.642
Return on Invested Capital 3.991

BDX Capital Structure

Total Debt to Total Equity 80.80
Total Debt to Total Capital 44.69
Total Debt to Total Assets 36.517
Long-Term Debt to Equity 71.869
Long-Term Debt to Total Capital 39.751
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Becton Dickinson & Co. - BDX

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
20.25B 18.87B 19.37B 20.18B
Sales Growth
+18.29% -6.81% +2.66% +4.16%
Cost of Goods Sold (COGS) incl D&A
10.77B 10.39B 11.20B 11.05B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
2.13B 2.10B 2.16B 2.14B
Depreciation
731.00M 672.00M 696.00M 676.00M
Amortization of Intangibles
1.40B 1.43B 1.47B 1.47B
COGS Growth
+12.91% -3.52% +7.78% -1.33%
Gross Income
9.48B 8.48B 8.17B 9.13B
Gross Income Growth
+25.06% -10.54% -3.62% +11.69%
Gross Profit Margin
+46.80% +44.92% +42.17% +45.22%
2021 2022 2023 2024 5-year trend
SG&A Expense
6.21B 5.96B 5.96B 6.05B
Research & Development
1.34B 1.26B 1.24B 1.19B
Other SG&A
4.87B 4.71B 4.73B 4.86B
SGA Growth
- +14.48% -3.88% +1.37%
Other Operating Expense
- (4.00M) 9.00M (9.00M)
Unusual Expense
788.00M 264.00M 339.00M 676.00M
EBIT after Unusual Expense
2.48B 2.25B 1.86B 2.41B
Non Operating Income/Expense
229.00M (67.00M) 257.00M 122.00M
Non-Operating Interest Income
9.00M 16.00M 49.00M 163.00M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
469.00M 398.00M 452.00M 528.00M
Interest Expense Growth
-11.17% -15.14% +13.57% +16.81%
Gross Interest Expense
513.00M 444.00M 503.00M 585.00M
Interest Capitalized
44.00M 46.00M 51.00M 57.00M
Pretax Income
2.24B 1.78B 1.66B 2.00B
Pretax Income Growth
+127.61% -20.47% -6.79% +20.64%
Pretax Margin
+11.07% +9.45% +8.58% +9.94%
Income Tax
150.00M 148.00M 132.00M 300.00M
Income Tax - Current - Domestic
148.00M 49.00M 451.00M 149.00M
Income Tax - Current - Foreign
290.00M 228.00M 303.00M 362.00M
Income Tax - Deferred - Domestic
(286.00M) (96.00M) (644.00M) (169.00M)
Income Tax - Deferred - Foreign
(2.00M) (33.00M) 22.00M (42.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.09B 1.64B 1.53B 1.71B
Minority Interest Expense
- - - -
-
Net Income
2.09B 1.64B 1.53B 1.71B
Net Income Growth
+139.36% -21.85% -6.42% +11.44%
Net Margin Growth
+10.33% +8.66% +7.90% +8.45%
Extraordinaries & Discontinued Operations
- - 144.00M (46.00M)
-
Discontinued Operations
- - 144.00M (46.00M)
-
Net Income After Extraordinaries
2.09B 1.78B 1.48B 1.71B
Preferred Dividends
- 90.00M 90.00M 60.00M
Net Income Available to Common
2.00B 1.69B 1.42B 1.71B
EPS (Basic)
6.9204 5.9262 4.9741 5.8841
EPS (Basic) Growth
+151.71% -14.37% -16.07% +18.29%
Basic Shares Outstanding
289.29M 285.00M 286.28M 289.76M
EPS (Diluted)
6.8541 5.8776 4.9377 5.8589
EPS (Diluted) Growth
+152.36% -14.25% -15.99% +18.66%
Diluted Shares Outstanding
292.09M 287.36M 288.39M 291.01M
EBITDA
5.40B 4.62B 4.36B 5.23B
EBITDA Growth
+29.10% -14.54% -5.65% +20.06%
EBITDA Margin
+26.69% +24.47% +22.49% +25.92%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 271.25
Number of Ratings 19 Current Quarters Estimate 3.567
FY Report Date 06 / 2025 Current Year's Estimate 14.426
Last Quarter’s Earnings 3.28 Median PE on CY Estimate N/A
Year Ago Earnings 13.14 Next Fiscal Year Estimate 15.659
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 12 12 14 14
Mean Estimate 3.57 4.15 14.43 15.66
High Estimates 3.70 4.23 14.52 15.91
Low Estimate 3.49 4.03 14.30 15.43
Coefficient of Variance 2.04 1.80 0.38 0.75

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 10 10 12
OVERWEIGHT 5 5 5
HOLD 4 4 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Becton Dickinson & Co. - BDX

Date Name Shares Transaction Value
Mar 28, 2025 Gregory J. Hayes Director 796 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Richard E. Byrd EVP & President Interventional 6,952 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $230 per share 1,598,960.00
Feb 13, 2025 Bertram L. Scott Director 36,033 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $227.99 per share 8,215,163.67
Feb 7, 2025 Christopher Ian Montague Jones Director 10,662 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 7, 2025 Carrie L. Byington Director 1,552 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 10, 2025 Shana Carol Neal EVP and Chief People Officer 16,941 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jan 10, 2025 Shana Carol Neal EVP and Chief People Officer 337 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jan 10, 2025 Shana Carol Neal EVP and Chief People Officer 448 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jan 10, 2025 Shana Carol Neal EVP and Chief People Officer 558 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jan 10, 2025 Shana Carol Neal EVP and Chief People Officer 16,201 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $235 per share 3,807,235.00
Jan 10, 2025 Shana Carol Neal EVP and Chief People Officer 16,989 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 0.00
Jan 10, 2025 Shana Carol Neal EVP and Chief People Officer 17,021 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jan 10, 2025 Shana Carol Neal EVP and Chief People Officer 16,910 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 0.00
Jan 10, 2025 Shana Carol Neal EVP and Chief People Officer 16,831 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 0.00
Jan 10, 2025 Shana Carol Neal EVP and Chief People Officer 16,862 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Aug 16, 2024 Roland Goette EVP and President EMEA N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Aug 16, 2024 Roland Goette EVP and President EMEA 12,585 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $234.08 per share 2,945,896.80
Aug 16, 2024 Roland Goette EVP and President EMEA 16,603 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $132.54 per share 2,200,561.62
Jul 3, 2024 Thomas J. Spoerel SVPController & Chief Acct Off 1,928 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 0.00
May 17, 2024 Roland Goette EVP and President EMEA 11,308 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $237.46 per share 2,685,197.68

Becton Dickinson & Co. in the News